Ticker Details
India Globalization Capital, Inc. India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats.
IPO Date:	June 1, 2006
Sector:	Industrials
Industry:	Trading Companies and Distributors
Market Cap:	$24.71M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.08 | 5.50%
Avg Daily Range (30 D):	$0.01 | 3.42%
Avg Daily Range (90 D):	$0.01 | 3.55%

Institutional Daily Volume
Avg Daily Volume:	.86M
Avg Daily Volume (30 D):	.38M
Avg Daily Volume (90 D):	.65M

Trade Size
Avg Trade Size (Sh.):	377
Avg Trade Size (Sh.) (30 D):	591
Avg Trade Size (Sh.) (90 D):	651

Institutional Trades
Total Institutional Trades:	84
Avg Institutional Trade:	$2.02M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	.22M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.15M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	473.34K

News

Aug 12, 2025 @ 5:00 PM Cannabinoid Clinical Trial Pipeline Gains Momentum... Source: Delveinsight

Jul 10, 2025 @ 5:00 PM Cannabinoid Agonist Clinical Trial Pipeline Appear... Source: Delveinsight

Jul 6, 2023 @ 12:03 PM Why VBI Vaccines Are Trading Lower By Over 23%; He... Source: Lisa Levin

Mar 20, 2023 @ 12:45 PM IGC Announces Rebranding, Changes Name to IGC Pha... Source: IGC Pharma, Inc.

Feb 15, 2023 @ 12:41 AM IGC Reports Financial Results for Third Fiscal Qua... Source: INDIA GLOBALIZATION CAPITAL INC.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.07	$-.02	$-.02
Diluted EPS	$-.07	$-.02	$-.02
Revenue	$1.11M	$.19M	$.33M
Gross Profit	$.51M	$.1M	$.15M
Net Income / Loss	$-6.45M	$-1.82M	$-1.6M
Operating Income / Loss	$-8.09M	$-2.9M	$-1.91M
Cost of Revenue	$.6M	$.09M	$.17M
Net Cash Flow	$-.47M	$.65M	$.02M
PE Ratio

Splits
Apr 19, 2013	1:10